Alpha Cubed Investments, LLC Amgen Inc Transaction History

Alpha Cubed Investments, LLC

$2.24 Billion
Q3 2024

A detailed history of Alpha Cubed Investments, LLC transactions in Amgen Inc stock. As of the latest transaction made, Alpha Cubed Investments, LLC holds 146,569 shares of AMGN stock, worth $38.6 Million. This represents 2.11% of its overall portfolio holdings.

Number of Shares

146,569

Previous 155,484 5.73%

Holding current value

$38.6 Million

Previous $48.6 Million 2.79%

% of portfolio

2.11%

Previous 2.32%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 07, 2024	SELL	$309.38 - $337.38 $2.76 Million - $3.01 Million	-8,915 Reduced 5.73%	146,569 $47.2 Million
Q2 2024 Jul 15, 2024	BUY	$262.75 - $319.31 $7.64 Million - $9.28 Million	29,068 Added 22.99%	155,484 $48.6 Million
Q1 2024 Apr 22, 2024	BUY	$268.87 - $324.56 $277,473 - $334,945	1,032 Added 0.82%	126,416 $35.9 Million
Q4 2023 Feb 05, 2024	BUY	$255.7 - $288.46 $681,951 - $769,322	2,667 Added 2.17%	125,384 $36.1 Million
Q3 2023 Oct 19, 2023	BUY	$218.65 - $271.46 $5.28 Million - $6.56 Million	24,162 Added 24.52%	122,717 $33 Million
Q2 2023 Jul 20, 2023	BUY	$214.27 - $253.37 $4.02 Million - $4.75 Million	18,753 Added 23.5%	98,555 $21.9 Million
Q1 2023 Apr 26, 2023	BUY	$225.79 - $275.2 $2.44 Million - $2.97 Million	10,787 Added 15.63%	79,802 $19.3 Million
Q4 2022 Jan 25, 2023	SELL	$229.03 - $291.01 $2.7 Million - $3.43 Million	-11,780 Reduced 14.58%	69,015 $0
Q3 2022 Nov 03, 2022	SELL	$224.46 - $253.15 $2.51 Million - $2.83 Million	-11,174 Reduced 12.15%	80,795 $18.2 Million
Q2 2022 Jul 22, 2022	SELL	$230.71 - $256.74 $578,851 - $644,160	-2,509 Reduced 2.66%	91,969 $22.4 Million
Q1 2022 Apr 22, 2022	BUY	$219.27 - $242.57 $3.8 Million - $4.2 Million	17,310 Added 22.43%	94,478 $22.8 Million
Q4 2021 Jan 19, 2022	SELL	$198.88 - $227.6 $49,322 - $56,444	-248 Reduced 0.32%	77,168 $17.4 Million
Q3 2021 Oct 26, 2021	SELL	$212.27 - $248.7 $5.89 Million - $6.9 Million	-27,744 Reduced 26.38%	77,416 $16.5 Million
Q2 2021 Jul 20, 2021	SELL	$233.58 - $259.14 $709,382 - $787,008	-3,037 Reduced 2.81%	105,160 $25.6 Million
Q1 2021 Apr 23, 2021	BUY	$221.91 - $258.6 $1.31 Million - $1.53 Million	5,898 Added 5.77%	108,197 $26.9 Million
Q4 2020 Jan 29, 2021	SELL	$216.38 - $257.67 $226,549 - $269,780	-1,047 Reduced 1.01%	102,299 $23.5 Million
Q3 2020 Oct 14, 2020	BUY	$234.65 - $260.95 $1.05 Million - $1.17 Million	4,482 Added 4.53%	103,346 $26.3 Million
Q2 2020 Jul 13, 2020	SELL	$197.81 - $242.74 $1.56 Million - $1.91 Million	-7,867 Reduced 7.37%	98,864 $23.3 Million
Q1 2020 Apr 10, 2020	SELL	$182.24 - $241.7 $1.58 Million - $2.09 Million	-8,652 Reduced 7.5%	106,731 $21.6 Million
Q4 2019 Jan 17, 2020	BUY	$189.21 - $243.2 $761,759 - $979,123	4,026 Added 3.62%	115,383 $27.8 Million
Q3 2019 Oct 18, 2019	BUY	$174.11 - $208.62 $1.13 Million - $1.35 Million	6,463 Added 6.16%	111,357 $21.5 Million
Q2 2019 Jul 19, 2019	BUY	$166.7 - $195.41 $1.46 Million - $1.71 Million	8,773 Added 9.13%	104,894 $19.3 Million
Q1 2019 Apr 26, 2019	BUY	$180.87 - $203.88 $320,320 - $361,071	1,771 Added 1.88%	96,121 $18.3 Million
Q4 2018 Jan 29, 2019	SELL	$178.4 - $208.25 $1.73 Million - $2.02 Million	-9,696 Reduced 9.32%	94,350 $18.4 Million
Q3 2018 Oct 25, 2018	BUY	$185.29 - $208.89 $494,724 - $557,736	2,670 Added 2.63%	104,046 $21 Million
Q2 2018 Jul 26, 2018	BUY	$166.05 - $186.51 $135,828 - $152,565	818 Added 0.81%	101,376 $18.7 Million
Q1 2018 May 09, 2018	BUY	$169.43 - $198.0 $131,647 - $153,846	777 Added 0.78%	100,558 $17.1 Million
Q4 2017 Feb 09, 2018	BUY	$168.79 - $188.59 $1.93 Million - $2.16 Million	11,429 Added 12.94%	99,781 $17.4 Million
Q3 2017 Oct 23, 2017	BUY	$167.29 - $191.0 $14.8 Million - $16.9 Million	88,352	88,352 $16.5 Million

Others Institutions Holding AMGN

# of Institutions

3,125

Shares Held

409M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $141B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Alpha Cubed Investments, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Alpha Cubed Investments, LLC with notifications on news.

Account

Alpha Cubed Investments, LLC Amgen Inc Transaction History